Loading
Latest filing published 23 Sept 2026 for 엘앤씨바이오. Read the official filing
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
손석우 (senior executive) discloses dealings in 엘앤씨바이오 to DART (FSS). Over a trading history stretching from 29 August 2025 to 23 September 2026, the count stands at 2 filings.
The open-market record is one-sided, with 2 purchases worth €111k and not one sale. No amount is published for 1 filing, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2026: 2 purchases and no sales on the market.
The newest entry dates from 23 September 2026: an open-market purchase, in 엘앤씨바이오. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.